Literature DB >> 20505069

Resting-state perfusion in nonmedicated schizophrenic patients: a continuous arterial spin-labeling 3.0-T MR study.

Lukas Scheef1, Christoph Manka, Marcel Daamen, Kai-Uwe Kühn, Wolfgang Maier, Hans H Schild, Frank Jessen.   

Abstract

PURPOSE: To determine whether well-described patterns of altered perfusion in schizophrenia can be identified by using continuous arterial spin labeling (CASL) with a whole-brain imaging sequence.
MATERIALS AND METHODS: This study was approved by the ethics committee of the local institutional review board, and written informed consent was obtained from all subjects. CASL was used to compare cerebral perfusion between 11 nonmedicated patients with schizophrenia and 25 healthy control subjects. Since antipsychotic medication may affect perfusion, only drug-free subjects were examined. Resting-state perfusion, as measured in terms of regional cerebral blood flow, was compared voxel wise by using an analysis of variance design in a statistical parametric mapping program, with patient age and sex as covariates.
RESULTS: Compared with the healthy control subjects, the schizophrenic patients had extensive areas of hypoperfusion in the frontal lobes bilaterally, in the anterior and medial cingulate gyri, and in the parietal lobes bilaterally. Increased perfusion was observed in the cerebellum, brainstem, and thalamus of the schizophrenic patients as compared with the perfusion in these areas in the control subjects.
CONCLUSION: CASL in schizophrenia revealed patterns of hypo- and hyperperfusion similar to the perfusion patterns in previously published positron emission tomographic and single photon emission computed tomographic studies. The advantages of CASL, including independence from injected contrast agents, no irradiation, and fast acquisition time, may facilitate intensive perfusion studies of the early recognition of schizophrenia and other psychiatric disorders, as well as longitudinal disease-monitoring research of these conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20505069     DOI: 10.1148/radiol.10091224

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  39 in total

1.  Resting quantitative cerebral blood flow in schizophrenia measured by pulsed arterial spin labeling perfusion MRI.

Authors:  Amy Pinkham; James Loughead; Kosha Ruparel; Wen-Chau Wu; Eve Overton; Raquel Gur; Ruben Gur
Journal:  Psychiatry Res       Date:  2011-08-09       Impact factor: 3.222

2.  Accelerated white matter aging in schizophrenia: role of white matter blood perfusion.

Authors:  Susan Wright; Peter Kochunov; Joshua Chiappelli; Robert McMahon; Florian Muellerklein; S Andrea Wijtenburg; Michael G White; Laura M Rowland; L Elliot Hong
Journal:  Neurobiol Aging       Date:  2014-02-28       Impact factor: 4.673

3.  Hyperperfusion in progressive multifocal leukoencephalopathy is associated with disease progression and absence of immune reconstitution inflammatory syndrome.

Authors:  Michael N Khoury; Sarah Gheuens; Long Ngo; Xiaoen Wang; David C Alsop; Igor J Koralnik
Journal:  Brain       Date:  2013-10-01       Impact factor: 13.501

Review 4.  Applications of arterial spin labeled MRI in the brain.

Authors:  John A Detre; Hengyi Rao; Danny J J Wang; Yu Fen Chen; Ze Wang
Journal:  J Magn Reson Imaging       Date:  2012-01-13       Impact factor: 4.813

Review 5.  Arterial spin labeling for the measurement of cerebral perfusion and angiography.

Authors:  Peter Jezzard; Michael A Chappell; Thomas W Okell
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-23       Impact factor: 6.200

6.  Increased hippocampal blood volume and normal blood flow in schizophrenia.

Authors:  Pratik Talati; Swati Rane; Jack Skinner; John Gore; Stephan Heckers
Journal:  Psychiatry Res       Date:  2015-04-03       Impact factor: 3.222

7.  Static and dynamic characteristics of cerebral blood flow during the resting state in schizophrenia.

Authors:  Jochen Kindler; Kay Jann; Philipp Homan; Martinus Hauf; Sebastian Walther; Werner Strik; Thomas Dierks; Daniela Hubl
Journal:  Schizophr Bull       Date:  2013-12-10       Impact factor: 9.306

8.  Intrinsic hippocampal activity as a biomarker for cognition and symptoms in schizophrenia.

Authors:  Jason R Tregellas; Jason Smucny; Josette G Harris; Ann Olincy; Keeran Maharajh; Eugene Kronberg; Lindsay C Eichman; Emma Lyons; Robert Freedman
Journal:  Am J Psychiatry       Date:  2014-05       Impact factor: 18.112

Review 9.  Neuroimaging biomarkers for early drug development in schizophrenia.

Authors:  Jason R Tregellas
Journal:  Biol Psychiatry       Date:  2013-10-04       Impact factor: 13.382

10.  Altered Glutamate and Regional Cerebral Blood Flow Levels in Schizophrenia: A 1H-MRS and pCASL study.

Authors:  S Andrea Wijtenburg; Susan N Wright; Stephanie A Korenic; Frank E Gaston; Nkemdilim Ndubuizu; Joshua Chiappelli; Robert P McMahon; Hongji Chen; Anya Savransky; Xiaoming Du; Danny J J Wang; Peter Kochunov; L Elliot Hong; Laura M Rowland
Journal:  Neuropsychopharmacology       Date:  2016-08-26       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.